logo

Astellas Pharma Inc. (ALPMY)



Trade ALPMY now with
  Date
  Headline
5/29/2020 8:03:17 AM Pfizer And Astellas Pharma Announce Final Results From Overall Survival Analysis Of Phase 3 PROSPER Trial
5/29/2020 2:42:24 AM Astellas Pharma: XTANDI Approved By Japan MHLW For Treatment Of Prostate Cancer With Distant Metastasis
5/20/2020 10:56:29 PM European Medicines Agency Accepts Astellas' Marketing Authorization Application For Roxadustat
5/14/2020 5:48:38 AM Astellas Pharma FY Core Profit Decline 10.5% To 223.18 Bln Yen
2/11/2020 8:04:35 AM Astellas Pharma And Pfizer Announce Results Of Final Overall Survival Analysis From Phase 3 PROSPER Trial
1/30/2020 12:10:03 AM Astellas Submits SNDA For Approval Of Evrenzo For Anemia Associated With CKD In Non-Dialysis Dependent Patients In Japan
1/15/2020 8:24:24 AM Astellas Pharma Completes Acquisition Of Audentes Therapeutics
1/14/2020 2:30:03 AM Astellas, Adaptimmune Enter Co-development And Co-commercialization Agreement
12/2/2019 8:11:35 PM Astellas Presents New Data On XOSPATA In FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia